Tolerability of Rebif® (Interferon-beta 1-A) Therapy in Korean Patients With Multiple Sclerosis

NCT01074346 · clinicaltrials.gov ↗

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Interferon-β-1a

Sponsor

Merck KGaA, Darmstadt, Germany